← Leaderboards
Jonathan D. Licht
Mount Sinai School Of Medicine Of Cuny
$22,549,031
Attributed
$26,463,398
Total exposure
16
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,356,006 · 18
By mechanism
R01$21,153,136 · 10
U54$13,311,907 · 2
P30$5,921,568 · 3
P01$713,937 · 1
T32$251,458 · 1
R13$4,000 · 1
Top collaborators
- Keiran Smalley9 shared
- Thomas V O'Halloran6 shared
- James W Harbour5 shared
- Mingyi Xie5 shared
Others in their field
Top investigators on “Gene Expression”
- Jeffrey P Krischer · University Of South Florida$137,481,663
- Eric S Lander · Whitehead Institute For Biomedical Res$128,154,716
- Stacey Gabriel · Massachusetts Institute Of Technology$86,302,566
- Bruce W Stillman · Cold Spring Harbor Laboratory$82,324,317
- Michael P Snyder · Yale University$75,701,723
- Ronald G Crystal · Weill Medical College Of Cornell Univ$74,774,977
Research focus
Gene ExpressionGenesCellsMutationPathway InteractionsChromatinMalignant NeoplasmsMediatingGenetic TranscriptionProteinsTumorEpigenetic ProcessMutantAffectCell LineProgramsPreventGeneticMolecularTranscription FactorGene Expression RegulationTumor Suppressor ProteinsSignal TransductionMutate
Grant awards (79)
Histone fold Mutations in Cancer Pathogenesis$705,611
R01 · FY2025 · CA · contact PI
Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasis$651,147
R01 · FY2025 · CA
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia$503,845
R01 · FY2025 · CA
Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma$485,968
R01 · FY2025 · CA
University of Florida Health Cancer Center Support Grant$2,134,999
P30 · FY2024 · CA · contact PI
Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasis$618,592
R01 · FY2024 · CA
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia$478,652
R01 · FY2024 · CA
Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma$463,483
R01 · FY2024 · CA
Leadership, Planning, and Evaluation$422,844
P30 · FY2024 · CA · contact PI
Histone fold Mutations in Cancer Pathogenesis$335,166
R01 · FY2024 · CA · contact PI
Developmental Funds$305,000
P30 · FY2024 · CA · contact PI
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia$81,624
R01 · FY2024 · CA
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia$26,469
R01 · FY2024 · CA
University of Florida Health Cancer Center Support Grant$2,134,999
P30 · FY2023 · CA · contact PI
Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasis$638,384
R01 · FY2023 · CA
Exploring microRNA degradation in T-cell acute lymphoblastic leukemia$503,845
R01 · FY2023 · CA
Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma$478,486
R01 · FY2023 · CA
Leadership, Planning, and Evaluation$422,844
P30 · FY2023 · CA · contact PI
Histone fold Mutations in Cancer Pathogenesis$345,749
R01 · FY2023 · CA · contact PI
Developmental Funds$305,000
P30 · FY2023 · CA · contact PI
UF Health Cancer Center Support Grant - Training Navigator Supplement$195,882
P30 · FY2023 · CA · contact PI
Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasis$638,640
R01 · FY2022 · CA
Defining and targeting epigenetic plasticity-driven drug resistance and immune escape in melanoma$498,307
R01 · FY2022 · CA
Histone fold Mutations in Cancer Pathogenesis$352,805
R01 · FY2022 · CA · contact PI
Characterization and targeting of the epigenetic state underlying uveal melanoma liver metastasis$684,278
R01 · FY2021 · CA
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer$500,000
U54 · FY2020 · CA
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy$390,734
R01 · FY2020 · CA · contact PI
KDM6A mutation as an epigenetic driver of multiple myeloma$56,953
R01 · FY2020 · CA · contact PI
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer$2,004,909
U54 · FY2019 · CA
Project 2: Molecular Modulation of Chromatin and Nuclear Structure in Cancer$582,074
U54 · FY2019 · CA · contact PI
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy$338,378
R01 · FY2019 · CA · contact PI
UTX, MLL AND PATHOGENIC DEREGULATION OF HISTONE METHYLATION IN MULTIPLE MYELOMA$336,968
R01 · FY2019 · CA · contact PI
2019 Cancer Genetics and Epigenetics GRC/GRS$4,000
R13 · FY2019 · CA · contact PI
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer$2,095,133
U54 · FY2018 · CA
Project 2: Molecular Modulation of Chromatin and Nuclear Structure in Cancer$677,567
U54 · FY2018 · CA · contact PI
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy$348,844
R01 · FY2018 · CA · contact PI
UTX, MLL AND PATHOGENIC DEREGULATION OF HISTONE METHYLATION IN MULTIPLE MYELOMA$347,390
R01 · FY2018 · CA · contact PI
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer$1,762,723
U54 · FY2017 · CA
Project 2: Molecular Modulation of Chromatin and Nuclear Structure in Cancer$562,587
U54 · FY2017 · CA · contact PI
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy$348,844
R01 · FY2017 · CA · contact PI
UTX, MLL AND PATHOGENIC DEREGULATION OF HISTONE METHYLATION IN MULTIPLE MYELOMA$347,390
R01 · FY2017 · CA · contact PI
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer$2,074,472
U54 · FY2016 · CA
Project 2: Molecular Modulation of Chromatin and Nuclear Structure in Cancer$542,300
U54 · FY2016 · CA · contact PI
The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy$348,844
R01 · FY2016 · CA · contact PI
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer$1,989,491
U54 · FY2015 · CA
Project 2: Molecular Modulation of Chromatin and Nuclear Structure in Cancer$520,651
U54 · FY2015 · CA · contact PI
UTX, MLL AND PATHOGENIC DEREGULATION OF HISTONE METHYLATION IN MULTIPLE MYELOMA$307,622
R01 · FY2015 · CA · contact PI
UTX, MLL and Pathogenic Deregulation of Histone Methylation in Multiple Myeloma$51,435
R01 · FY2015 · CA · contact PI
UTX, MLL and Pathogenic Deregulation of Histone Methylation in Multiple Myeloma$373,041
R01 · FY2014 · CA · contact PI
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma$288,529
R01 · FY2013 · CA · contact PI
Clinical Oncology Research Training Program$251,458
T32 · FY2013 · CA · contact PI
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma$306,945
R01 · FY2012 · CA · contact PI
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma$306,945
R01 · FY2011 · CA · contact PI
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma$316,438
R01 · FY2010 · CA · contact PI
SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT$273,189
R01 · FY2010 · CA · contact PI
Transcriptional Functions and Targets of the MMSET Protein of t(4:14) Myeloma$316,438
R01 · FY2009 · CA · contact PI
SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT$273,189
R01 · FY2009 · CA · contact PI
The Molecular Pathology of Myeloproliferative Disease$530,122
R01 · FY2008 · HL · contact PI
SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT$273,189
R01 · FY2008 · CA · contact PI
The Molecular Pathology of Myeloproliferative Disease$540,938
R01 · FY2007 · HL · contact PI
The PLZF Protein of t(11;17)-Promyelocytic Leukemia$382,145
R01 · FY2007 · CA · contact PI
SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT$273,189
R01 · FY2007 · CA · contact PI
The Molecular Pathology of Myeloproliferative Disease$588,707
R01 · FY2006 · HL · contact PI
The PLZF Protein of t(11;17)-Promyelocytic Leukemia$390,382
R01 · FY2006 · CA · contact PI
SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT$315,817
R01 · FY2006 · CA · contact PI
The Molecular Pathology of Myeloproliferative Disease$1
R01 · FY2006 · HL · contact PI
The Molecular Pathology of Myeloproliferative Disease$620,250
R01 · FY2005 · HL
The PLZF Protein of t(11;17)-Promyelocytic Leukemia$390,258
R01 · FY2005 · CA
SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT$322,262
R01 · FY2005 · CA
The PLZF Protein of t(11;17)-Promyelocytic Leukemia$379,845
R01 · FY2004 · CA
SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT$322,262
R01 · FY2004 · CA
The PLZF Protein of t(11;17)-Promyelocytic Leukemia$403,531
R01 · FY2003 · CA
SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT$322,262
R01 · FY2003 · CA
SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT$322,262
R01 · FY2002 · CA
Convergent functions of p53 and BRCA1 in gene regulation$237,979
P01 · FY2002 · CA
SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT$322,262
R01 · FY2001 · CA
Convergent functions of p53 and BRCA1 in gene regulation$237,979
P01 · FY2001 · CA
TRANSCRIPTIONAL REPRESSION BY THE WTI PROTEIN$284,285
R01 · FY2000 · CA
Convergent functions of p53 and BRCA1 in gene regulation$237,979
P01 · FY2000 · CA